Ostéoporose chez le sujet âgé
Tài liệu tham khảo
Becker, 2006, Characteristics of elderly patients admitted to an urban tertiary care hospital with osteoporotic fractures: correlations with risk factors, fracture type, gender and ethnicity, Osteoporos Int, 17, 410, 10.1007/s00198-005-0001-1
World Health Organisation Assessment of fracture risk and its applications to screening for postmenopausal osteoporosis. WHO technical report series, N843, Geneva: Switzerland World Health Organisation, 1994.
Ralston, 2005, Genetic determinants of osteoporosis, Curr Opin Rheumatol, 17, 475, 10.1097/01.bor.0000166385.62851.92
Eckstein, 2004, Determinants and heterogeneity of mechanical competence throughout the thoracolumbar spine of elderly women and men, Bone, 35, 364, 10.1016/j.bone.2004.04.008
Johnell, 2005, Predictive value of BMD for hip and other fractures, J Bone Miner Res, 20, 1185, 10.1359/JBMR.050304
Raisz, 2005, Pathogenesis of osteoporosis: concepts, conflicts, and prospects, J Clin Invest, 115, 3318, 10.1172/JCI27071
Raisz, 2003, Pathogenesis of osteoporosis, Endocrinol Metab Clin North Am, 32, 15, 10.1016/S0889-8529(02)00055-5
Priestwood and Duque. Chapter on osteoporosis. In: Hazzard textbook of medicine 5th edition, chapter 76.
Cummings, 2002, Epidemiology and outcomes of osteoporotic fractures, Lancet, 359, 1761, 10.1016/S0140-6736(02)08657-9
Dargent-Molina, 2004, Epidemiology and risk factors for osteoporosis, Rev Med Interne, 25, S517, 10.1016/S0248-8663(04)80049-3
Blain, 2004, Osteoporosis in men: epidemiology, physiopathology, diagnosis, prevention and treatment, Rev Med Interne, 25, S552, 10.1016/S0248-8663(04)80054-7
Wallace, 2000, Bone health in nursing home residents, JAMA, 284, 1018, 10.1001/jama.284.8.1018
Siris, 2006, The effect of age and bone mineral density on the absolute, excess, and relative risk of fracture in postmenopausal women aged 50-99: results from the National Osteoporosis Risk Assessment (NORA), Osteoporos Int, 17, 565, 10.1007/s00198-005-0027-4
Johnell, 2005, Epidemiology of osteoporotic fractures, Osteoporos Int, 16, S3, 10.1007/s00198-004-1702-6
Klotzbuecher, 2000, Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis, J Bone Miner Res, 15, 721, 10.1359/jbmr.2000.15.4.721
Baudoin, 1996, Hip fractures in France: the magnitude and perspective of the problem, Osteoporos Int, 6, 1, 10.1007/BF01623756
Osteoporosis in Europe: indicators of progress. Report of International Osteoporosis Foundation February 2005. http://www.osteofound.org/advocacy_policy/ eu_policy_project/pdf/indicators_of_progress.pdf. Consulté le 14.02.06.
Maravic, 2005, Incidence and cost of osteoporotic fractures in France during 2001 A methodological approach by the national hospital database, Osteoporos Int, 16, 1475, 10.1007/s00198-005-2031-0
Fontana, 2001, 17
No authors listed. Incidence of vertebral fracture in Europe: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res 2002, 17: 716-24.
Grados, 2004, Prevalence of vertebral fractures in French women older than 75 years from the EPIDOS study, Bone, 34, 362, 10.1016/j.bone.2003.11.008
Nevitt, 1993, Type of fall and risk of hip and wrist fractures: the study of osteoporotic fractures, J Am Geriatr Soc, 41, 1226, 10.1111/j.1532-5415.1993.tb07307.x
Kelsey, 1992, Risk factors for fractures of the distal forearm and proximal humerus, Am J Epidemiol, 135, 477, 10.1093/oxfordjournals.aje.a116314
Center, 1999, Mortality after all major types of osteoporotic fracture in men and women: an observational study, Lancet, 353, 878, 10.1016/S0140-6736(98)09075-8
Cooper, 1993, Population-based study of survival after osteoporotic fractures, Am J Epidemiol, 137, 1001, 10.1093/oxfordjournals.aje.a116756
Ishida, 2005, Factors affecting ambulatory status and survival of patients 90 years and older with hip fractures, Clin Orthop Relat Res, 208, 10.1097/01.blo.0000159156.40002.30
Ismail, 1998, Mortality associated with vertebral deformity in men and women: results from the European Prospective Osteoporosis Study (EPOS), Osteoporos Int, 8, 291, 10.1007/s001980050067
Hasserius, 2005, Long-term morbidity and mortality after a clinically diagnosed vertebral fracture in the elderly--a 12- and 22-year follow-up of 257 patients, Calcif Tissue Int, 76, 235, 10.1007/s00223-004-2222-2
Melton, 2000, Excess mortality following vertebral fracture, J Am Geriatr Soc, 48, 338, 10.1111/j.1532-5415.2000.tb02658.x
Kado, 2003, Incident vertebral fractures and mortality in older women: a prospective study, Osteoporos Int, 14, 589, 10.1007/s00198-003-1412-5
Fink, 2003, Disability after clinical fracture in postmenopausal women with low bone density: the fracture intervention trial (FIT), Osteoporos Int, 14, 69, 10.1007/s00198-002-1314-y
Cooper, 1992, Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota 1985-1989, J Bone Miner Res, 7, 221, 10.1002/jbmr.5650070214
Nevitt, 1998, The association of radiographically detected vertebral fractures with back pain and function: a prospective study, Ann Intern Med, 128, 793, 10.7326/0003-4819-128-10-199805150-00001
L’ostéoporose dans la Communauté Européenne: Plan d’Action-Rapport sur les étapes clés d’une Europe exempte de fractures par fragilité. Novembre 2003 http://www.osteofound.org/publications/eu_reports.html, consultéle 14/02/06.
Cooper, 1992, Hip fractures in the elderly: a world-wide projection, Osteoporos Int, 2, 285, 10.1007/BF01623184
De Laet, 1999, Incremental cost of medical care after hip fracture and first vertebral fracture: the Rotterdam study, Osteoporos Int, 10, 66, 10.1007/s001980050196
Kanis, 2002, Diagnosis of osteoporosis and assessment of fracture risk, Lancet, 359, 1929, 10.1016/S0140-6736(02)08761-5
Delaney, 2006, Strategies for the prevention and treatment of osteoporosis during early postmenopause, Am J Obstet Gynecol, 194, S12, 10.1016/j.ajog.2005.08.049
Gregg, 2000, Physical activity, falls, and fractures among older adults: a review of the epidemiologic evidence, J Am Geriatr Soc, 48, 883, 10.1111/j.1532-5415.2000.tb06884.x
Dargent-Molina, 1996, Fall-related factors and risk of hip fracture: the EPIDOS prospective study, Lancet, 348, 145, 10.1016/S0140-6736(96)01440-7
Retornaz, 2005, La réduction du risque de chute, Le rhumatologue, 23, 45
Taylor, 2004, Long-term prediction of incident hip fracture risk in elderly white women: study of osteoporotic fractures, J Am Geriatr Soc, 52, 1479, 10.1111/j.1532-5415.2004.52410.x
Montero-Odasso, 2005, Vitamin D in the aging musculoskeletal system: an authentic strength preserving hormone, Mol Aspects Med, 26, 203, 10.1016/j.mam.2005.01.005
Dargent-Molina, 2005, Identification of women at increased risk of osteoporosis: No need to use different screening tools at different ages, Maturitas, 6, 55
Saliba, 2005, Quality indicators for the management of medical conditions in nursing home residents, J Am Med Dir Assoc, 6, S36, 10.1016/j.jamda.2005.03.022
Retornaz, 2004, Secondary osteoporosis and internal medicine, Rev Med Interne, 25, S543, 10.1016/S0248-8663(04)80053-5
Kannus, 2005, Prevention of falls and consequent injuries in elderly people, Lancet, 366, 1885, 10.1016/S0140-6736(05)67604-0
Tinetti, 2003, Clinical practice Preventing falls in elderly persons, N Engl J Med, 348, 42, 10.1056/NEJMcp020719
Liu-Ambrose, 2005, The beneficial effects of group-based exercises on fall risk profile and physical activity persist 1 year postintervention in older women with low bone mass: follow-up after withdrawal of exercise, J Am Geriatr Soc, 53, 1767, 10.1111/j.1532-5415.2005.53525.x
Healey, 2004, Using targeted risk factor reduction to prevent falls in older in-patients: a randomised controlled trial, Age Ageing, 33, 390, 10.1093/ageing/afh130
Haines, 2004, Effectiveness of targeted falls prevention programme in subacute hospital setting: randomised controlled trial, BMJ, 328, 676, 10.1136/bmj.328.7441.676
Schoor, 2003, The Amsterdam Hip Protector Study: compliance and determinants of compliance, Osteoporos Int, 14, 353, 10.1007/s00198-003-1382-7
Sawka, 2005, Do hip protectors decrease the risk of hip fracture in institutional and community-dwelling elderly? A systematic review and meta-analysis of randomized controlled trials, Osteoporos Int, 16, 1461, 10.1007/s00198-005-1932-2
Parker, 2006, Effectiveness of hip protectors for preventing hip fractures in elderly people: systematic review, BMJ, 332, 571, 10.1136/bmj.38753.375324.7C
Rooij, 2006, Hip protectors to prevent femoral fracture, BMJ, 332, 559, 10.1136/bmj.332.7541.559
Gerdhem, 2005, Association between 25-hydroxy vitamin D levels, physical activity, muscle strength and fractures in the prospective population-based OPRA Study of Elderly Women, Osteoporos Int, 16, 1425, 10.1007/s00198-005-1860-1
Bischoff-Ferrari, 2005, Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials, JAMA, 293, 2257, 10.1001/jama.293.18.2257
Lips, 2001, Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications, Endocr Rev, 22, 477, 10.1210/er.22.4.477
Duque, 2005, 1, 25(OH)2D3 acts as a bone-forming agent in the hormone-independent senescence-accelerated mouse (SAM-P/6), Am J Physiol Endocrinol Metab, 288, E723, 10.1152/ajpendo.00180.2004
Duque, 2004, Vitamin D treatment of senescence accelerated mice (SAM-P/6) induces several regulators of stromal cell plasticity, Biogerontology, 5, 421, 10.1007/s10522-004-3192-5
Bischoff-Ferrari, 2004, Effect of Vitamin D on falls: a meta-analysis, JAMA, 291, 1999, 10.1001/jama.291.16.1999
Venning, 2005, Recent developments in vitamin D deficiency and muscle weakness among elderly people, BMJ, 330, 524, 10.1136/bmj.330.7490.524
Dhesi, 2004, Vitamin D supplementation improves neuromuscular function in older people who fall, Age Ageing, 33, 589, 10.1093/ageing/afh209
Bischoff-Ferrari, 2004, Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or =60 y, Am J Clin Nutr, 80, 752, 10.1093/ajcn/80.3.752
Ness, 2005, Use of hormone replacement therapy by postmenopausal women after publication of the Women's Health Initiative Trial, J Gerontol A Biol Sci Med Sci, 60, 460, 10.1093/gerona/60.4.460
Meier, 2005, Endocrine regulation of bone turnover in men, Clin Endocrinol (Oxf), 63, 603, 10.1111/j.1365-2265.2005.02333.x
Simon, 2005, Osteoporosis, Clin Geriatr Med, 21, 603, 10.1016/j.cger.2005.02.002
Seeman, 2004, Estrogen, androgen, and the pathogenesis of bone fragility in women and men, Curr Osteoporos Rep, 2, 90, 10.1007/s11914-004-0016-0
Epstein, 2005, Biological properties and mechanism of action of ibandronate: application to the treatment of osteoporosis, Bone, 37, 433, 10.1016/j.bone.2005.05.007
Boonen, 2004, Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: implications for the use of antiresorptive agents in the old and oldest old, J Am Geriatr Soc, 52, 1832, 10.1111/j.1532-5415.2004.52506.x
Hochberg, 2005, Effect of alendronate on the age-specific incidence of symptomatic osteoporotic fractures, J Bone Miner Res, 20, 971, 10.1359/JBMR.050104
Mc Clung, 2001, N Engl J Med, 344, 333, 10.1056/NEJM200102013440503
Miller, 2005, Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: a pooled analysis of nine clinical trials, J Bone Miner Res, 20, 2105, 10.1359/JBMR.050817
Ettinger, 1998, Clinic visits and hospital admissions for care of acid-related upper gastrointestinal disorders in women using alendronate for osteoporosis, Am J Manag Care, 4, 1377
Tashjian, 2006, Teriparatide human PTH(1-34): 2 5 years of experience on the use and safety of the drug for the treatment of osteoporosis, J Bone Miner Res, 21, 354, 10.1359/JBMR.051023
Traitement médicamenteux de l’ostéoporose post-ménopausique. Recommandations de l’Agence française de sécurité des produits sanitaires AFSSAPS, Actualisation 2006, http://www.afssaps.sante.fr.
Roux, 2006, Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors, J Bone Miner Res, 21, 536, 10.1359/jbmr.060101
Reginster, 2005, Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study, J Clin Endocrinol Metab, 90, 2816, 10.1210/jc.2004-1774